Aqemia: Revolutionizing Drug Discovery with Deep Physics and AI
Aqemia is a pioneering pharmatech company that is making significant waves in the field of drug discovery. By leveraging a unique combination of quantum-inspired physics and machine learning, Aqemia is transforming the way drugs are discovered and developed.
The company's mission is to scale the drug discovery process. Unlike conventional AI-based platforms, Aqemia's approach is truly innovative. It generates its own data using unique quantum physics algorithms, which have been the result of 12 years of research at prestigious institutions like Oxford, Cambridge, and ENS/CNRS. This enables the company to tackle drug discovery projects from their earliest stages, with an unprecedented pace and accuracy.
One of the key advantages of Aqemia's technology is its ability to guide the generative AI towards the right molecules. The 10,000x faster and more accurate physics algorithms allow for the efficient discovery of innovative drug candidates, making the drug discovery process more scalable and efficient.
Since its inception in 2019 as a deeptech spin-off from École normale supérieure, Aqemia has grown rapidly. In just three years, the company has assembled an amazing team of 50+ people, established and expanded collaborations with major pharmaceutical companies, and initiated its own drug discovery pipeline with multiple projects spanning from hit generation to in vivo assays.
Aqemia's goal is to massively accelerate research projects and scale to dozens of wholly or partly owned drug candidates. This is achieved by placing them into a constellation of biotech spin-offs to conduct clinical trials. The company's recent achievements, such as raising $30m to accelerate its proprietary therapeutic pipeline and announcing a major multi-year collaboration of $140 million with Sanofi, demonstrate its potential and the impact it is making in the industry.
At Aqemia, professionals from various disciplines come together to work towards a common goal. The team consists of passionate drug hunters, AI engineers, and developers who are committed to finding drugs at a high pace to cure diseases.
